The search for an AIDS cure has partly focused on ways to eradicate infected cells. Now, new research from Karolinska Institutet in Sweden and the University of Pennsylvania in the U.S. shows that this approach may not be ...
Dec 18, 2019
0
44
Neoadjuvant treatment with the CDK4/6 inhibitor ribociclib (Kisqali) and the aromatase inhibitor letrozole (Femara) produced response rates similar to multi-agent chemotherapy in patients with high-risk luminal B breast cancer, ...
Dec 12, 2019
0
2
UT Southwestern researchers have developed a software tool that uses artificial intelligence to recognize cancer cells from digital pathology images—giving clinicians a powerful way of predicting patient outcomes.
Dec 9, 2019
0
26
Biliary tract cancer is a type of cancer that occurs in the bile ducts, which transport bile from the liver to the duodenum. While generally rare, these cancers are relatively common in Asian populations. Patients with one ...
Dec 6, 2019
0
1
Parkinson's and multisystem atrophy (MSA), both neurodegenerative diseases, are associated with the accumulation of alpha-synuclein proteins in the brain. Researchers at the German Center for Neurodegenerative Diseases (DZNE) ...
Dec 5, 2019
0
26
The gut has long been suspected to play a role in autoimmune disease. A research team has now identified evidence of a potential mechanism.
Dec 4, 2019
0
947
Viruses get a bad rap as potential cancer-causers, but at least one class of viruses that commonly live on human skin—so-called "low-risk" human papillomaviruses—appear to play an unwitting role in protecting us against ...
Oct 30, 2019
0
303
Researchers from the UCLA Jonsson Comprehensive Cancer Center and other institutions in the U.S., Canada, the United Kingdom and Singapore, have identified 1,178 biomarkers in men's genomes—the complete set of genetic material ...
Oct 8, 2019
0
41
UNSW medical researchers have shown how a biomarker could help doctors more accurately diagnose one of the rarest types of ovarian cancer.
Oct 3, 2019
0
18
For more than a decade, scientist Stephen Albert Johnston and his team at Arizona State University's Biodesign Institute have pooled their energies into an often scoffed-at, high-risk, high-reward goal in medicine: to develop ...
Oct 2, 2019
0
261
